相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
Marie Batisse et al.
CANCER INVESTIGATION (2013)
Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management
Ilyess Zemmoura et al.
PITUITARY (2013)
Subclinical hyperfunctioning pituitary adenomas: The silent tumors
Odelia Cooper et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Familial pituitary adenomas - who should be tested for AIP mutations?
Marta Korbonits et al.
CLINICAL ENDOCRINOLOGY (2012)
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients
Laurent Vroonen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Biomarkers of aggressive pituitary adenomas
Ozgur Mete et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
Annamaria Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Radiation Therapy in the Management of Pituitary Adenomas
Jay S. Loeffler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Pituitary Carcinoma: Difficult Diagnosis and Treatment
Anthony P. Heaney
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes Clinical article
Jason P. Sheehan et al.
JOURNAL OF NEUROSURGERY (2011)
Atypical pituitary adenomas: incidence, clinical characteristics, and implications Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas
Maria Chiara Zatelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
Zachary M. Bush et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior
Zhe Bao Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Radiation treatment strategies for acromegaly
Nathan C. Rowland et al.
NEUROSURGICAL FOCUS (2010)
Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
C. Hagen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma
Luis V. Syro et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
KI-67 IN PITUITARY NEOPLASMS: A REVIEW-PART I
Fateme Salehi et al.
NEUROSURGERY (2009)
USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS: CASE REPORT
Safraz Mohammed et al.
NEUROSURGERY (2009)
Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients
Masami Ono et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
M. Filopanti et al.
PHARMACOGENOMICS JOURNAL (2008)
MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy
Kalman Kovacs et al.
ACTA NEUROPATHOLOGICA (2008)
P53 gene mutations in pituitary carcinomas
Yoshinori Tanizaki et al.
ENDOCRINE PATHOLOGY (2007)
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors
Anne Wierinckx et al.
ENDOCRINE-RELATED CANCER (2007)
Pituitary tumor enlargement in two patients with acromegaly during pegvisomant therapy
Lawrence A. Frohman et al.
PITUITARY (2007)
Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists
Lisa M. Neff et al.
PITUITARY (2007)
Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Corticotroph tumor progression after adrenalectomy in Cushing's disease:: A reappraisal of Nelson's syndrome
Guillaume Assie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings
Kalman Kovacs et al.
HUMAN PATHOLOGY (2007)
Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm
Luis V. Syro et al.
CLINICAL ENDOCRINOLOGY (2006)
The 2004 Who classification of pituitary tumors: comments
K Kovacs
ACTA NEUROPATHOLOGICA (2006)
CLINICAL REVIEW: A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly
S Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance
E Delgrange et al.
ACTA NEUROCHIRURGICA (2005)
Pituitary carcinoma with a single metastasis causing cervical spinal cord compression - Case report
J Ayuk et al.
JOURNAL OF NEUROSURGERY-SPINE (2005)
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: A mechanism underlying pituitary neoplasia
S Ezzat et al.
MOLECULAR ENDOCRINOLOGY (2004)
Crooke's cell adenoma of the pituitary - An aggressive variant of corticotroph adenoma
DH George et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Stereotactic radiosurgery XVI: A treatment for previously irradiated pituitary adenomas
FM Swords et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma
MP Gillam et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Pituitary carcinoma: An ultrastructural study of eleven cases
BW Scheithauer et al.
ULTRASTRUCTURAL PATHOLOGY (2001)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Pituitary carcinoma containing gonadotropins: Treatment by radical excision and cytotoxic chemotherapy: Case report
IE McCutcheon et al.
NEUROSURGERY (2000)
分享论文
